Back to drug safety directory
First-generation EGFR TKI (NSCLC, pancreatic cancer)Reviewed May 23, 2026

Erlotinib (Tarceva) and Ketamine Therapy | Tovani Health

Tarceva (Erlotinib) — First-generation EGFR TKI (NSCLC, pancreatic cancer)

Verdict at Tovani Health

Fully compatible; same EGFR TKI framework as osimertinib.

Erlotinib and ketamine have no clinically significant direct interaction. Largely supplanted by osimertinib for EGFR-mutant NSCLC but still in use. Same class side effect profile (rash, diarrhea, paronychia, ILD risk) and same CYP3A4 substrate caution that's about erlotinib levels, not ketamine.

If you take Tarceva regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.

How Tarceva interacts with ketamine

Reversible EGFR tyrosine kinase inhibitor. CYP3A4 + CYP1A2 substrate. No reciprocal effect on ketamine.

What we do at intake

Continue as prescribed.

Bottom line

Erlotinib and ketamine have no clinically significant direct interaction. Largely supplanted by osimertinib for EGFR-mutant NSCLC but still in use. Same class side effect profile (rash, diarrhea, paronychia, ILD risk) and same CYP3A4 substrate caution that's about erlotinib levels, not ketamine.

Ready to find out if at-home ketamine fits your situation?

We’ll note that you’re on Tarceva (Erlotinib) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.

Check eligibility (5 min, FL & NJ residents)

FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.

Clinically reviewed

Reviewed by Benjamin Soffer, DO on May 23, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.

This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.